Contrasting Ceres Ventures (OTCMKTS:CEVE) & Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare (NASDAQ:ADUS) and Ceres Ventures (OTCMKTS:CEVE) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Valuation and Earnings

This table compares Addus HomeCare and Ceres Ventures”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.15 billion	1.64	$73.60 million	$4.67	21.94
Ceres Ventures	N/A	N/A	N/A	N/A	N/A

Addus HomeCare has higher revenue and earnings than Ceres Ventures.

Profitability

This table compares Addus HomeCare and Ceres Ventures’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.36%	9.53%	6.81%
Ceres Ventures	N/A	N/A	N/A

Risk and Volatility

Addus HomeCare has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Ceres Ventures has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Addus HomeCare and Ceres Ventures, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1	2	6	1	2.70
Ceres Ventures	0	0	0	0	0.00

Addus HomeCare presently has a consensus price target of $135.44, indicating a potential upside of 32.17%. Given Addus HomeCare’s stronger consensus rating and higher possible upside, equities analysts plainly believe Addus HomeCare is more favorable than Ceres Ventures.

Insider and Institutional Ownership

95.4% of Addus HomeCare shares are held by institutional investors. 4.5% of Addus HomeCare shares are held by company insiders. Comparatively, 0.1% of Ceres Ventures shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Addus HomeCare beats Ceres Ventures on 10 of the 11 factors compared between the two stocks.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

About Ceres Ventures

Ceres Ventures, Inc., a development stage company, focuses on the research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air. Its technologies include BluFlow Nanoparticles, a proprietary system for formulating, producing, and deploying customizable absorbent nanoparticles to specific functionality for contaminant/chemical removal and extraction of valuable elements and compounds from water based solutions; BluFlow Advanced Ultrafiltration Technology, an automated process to recover water from waste or impure streams; and BluFlow Treatment System a water and wastewater treatment solution, which incorporates the BluFlow Nanoparticles and the BluFlow Advanced Ultrafiltration Technology to remove target elements, compounds, and pollutants, as well as purify water that may be suitable for reuse. Ceres Ventures, Inc.'s products are used in water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and valuable elements and compounds extraction applications. The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was founded in 2010 and is based in New York, New York.